Co-morbidity and use of medicines during the terminal stage of life in patients with COPD

S. A. Jansson, B. M. Sundblad, L. Nyström, P. Arvidsson, B. Lundbäck, K. Larsson (Stockholm, Umeå, Gothenburg, Sweden)

Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Session: Comorbidities and respiratory disease and late-breaking abstracts
Session type: Poster Discussion
Number: 3451
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. A. Jansson, B. M. Sundblad, L. Nyström, P. Arvidsson, B. Lundbäck, K. Larsson (Stockholm, Umeå, Gothenburg, Sweden). Co-morbidity and use of medicines during the terminal stage of life in patients with COPD. Eur Respir J 2013; 42: Suppl. 57, 3451

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Renal impairment a neglected comorbidity in patients with COPD
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016


Impact of comorbidities in COPD prognosys scores
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


The severity of anxiety in COPD patients (pts)
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


Comorbidities in patients with COPD and their impact on COPD course
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014

Predictors of psychiatric disorders in COPD patients
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013


The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013


Prevalence and characteristics of anxiety and depression in patients with advanced COPD
Source: International Congress 2015 – Best abstracts in chronic care
Year: 2015

Comorbidity in patients with COPD in Russia
Source: Annual Congress 2013 –COPD treatment
Year: 2013


Comparing the prevalence of depression and anxiety in patients admitted with an exacerbation of COPD using two scoring systems
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015


The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013


GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016


Changes in cognitive status across clinical stages in COPD
Source: International Congress 2015 – Rehabilitation, exercise, hospitalisation and COPD
Year: 2015


How beneficial might be using the Lüscher colour test in the psychological assessment of COPD patients?
Source: International Congress 2015 – Best abstracts in COPD management
Year: 2015

The distribution of phenotypes in a population of severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014



The impact of depression and anxiety on never-smokers COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016


Comorbidity in patients with IHD - the prevalence of COPD
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016

Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014


The most frequent comorbidies in COPD and their inflence on the prognosis of the disease
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013

Co-morbidities of COPD in primary care
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015

Impact of the nutritional status on pulmonary function in COPD patients
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013